Publications
51
Citations
610
Est. group size
~2
Recurring co-author estimate
Active years
50
Publishing since 1977
Charles W. Yates conducts medical research focused on tumors of the nervous system, particularly vestibular schwannomas (benign tumors affecting the hearing and balance nerve) and neurofibromatosis type 2, a genetic condition that causes such tumors. Much of the work tests drug treatments in laboratory and animal models to shrink tumors and prevent hearing loss, alongside studies of hearing and ear function. The research bridges surgical oncology of the head and neck with hearing rehabilitation.
Publication activity has been relatively steady at a few papers per year, with a notable increase in the most recent year.
Generated by claude-opus-4-8 from public bibliographic data · Jul 9, 2026
Typically publishes in teams of ~12 · 0% small-team papers (≤3 authors) · across 7 venues
- Hearing and Speech Perception are Associated with A/T/N Biomarkers of Alzheimer's Disease
Alzheimer s & Dementia · 2025
- Reduction of sporadic and neurofibromatosis type 2–associated vestibular schwannoma growth in vitro and in vivo after treatment with the c-Jun N-terminal kinase inhibitor AS602801
Journal of neurosurgery · 2022
- PAK1 inhibition reduces tumor size and extends the lifespan of mice in a genetically engineered mouse model of Neurofibromatosis Type 2 (NF2)
Human Molecular Genetics · 2021
- An assessment of a conical horn waveguide to represent the human eardrum
Journal of Physics D Applied Physics · 2018
- EXTH-13. REDUCTION OF TUMOR BURDEN AND HEARING LOSS WITH A MULTIPLE RECEPTOR TYROSINE KINASE INHIBITOR BRIGATINIB IN A GENETICALLY ENGINEERED MOUSE MODEL OF NEUROFIBROMATOSIS TYPE 2
Neuro-Oncology · 2018
- Chemopreventative celecoxib fails to prevent schwannoma formation or sensorineural hearing loss in genetically engineered murine model of neurofibromatosis type 2
Oncotarget · 2017
- Chemopreventative celecoxib fails to prevent schwannoma formation or sensorineural hearing loss in genetically engineered murine model of neurofibromatosis type 2
PMC · 2017
- Otology & Neurotology×8
- PLoS ONE×2
- Human Molecular Genetics×2
- PMC×2
- Alzheimer s & Dementia×2
- Evan C. Cumpston
Medicine · Indiana University
- Douglas J. Totten
Medicine · Indiana University
- Trisha Gupte
Medicine · University of Michigan
- Constantine L. Karras
Medicine · The Ohio State University
- Widya Adidharma
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Sep 1, 2026.
Claim or correct this profile